J&J’s Single Shot Is EU’s Fourth COVID-19 Vaccine – But Supplies Lag

55 Million Doses Due To Be Supplied In Q2

 
• By Andrew McConaghie
Janssen Leiden Netherlands
Development of the vaccine was led by the company's Janssen division in Leiden, Netherlands.

More from Vaccines

More from Pink Sheet